nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—SLC6A4—autistic disorder	0.344	0.565	CbGaD
Nortriptyline—HTR2A—autistic disorder	0.265	0.435	CbGaD
Nortriptyline—HTR2C—telencephalic ventricle—autistic disorder	0.0049	0.0353	CbGeAlD
Nortriptyline—HTR2A—cerebellar cortex—autistic disorder	0.00422	0.0305	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—autistic disorder	0.00412	0.0297	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—autistic disorder	0.00372	0.0269	CbGeAlD
Nortriptyline—HTR2A—pons—autistic disorder	0.00298	0.0215	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—autistic disorder	0.00246	0.0177	CbGeAlD
Nortriptyline—HTR6—forebrain—autistic disorder	0.00221	0.016	CbGeAlD
Nortriptyline—SLC6A4—hindbrain—autistic disorder	0.00219	0.0158	CbGeAlD
Nortriptyline—HTR6—telencephalon—autistic disorder	0.00203	0.0147	CbGeAlD
Nortriptyline—CHRM5—eye—autistic disorder	0.00195	0.0141	CbGeAlD
Nortriptyline—HTR1A—hindbrain—autistic disorder	0.00195	0.014	CbGeAlD
Nortriptyline—ADRA1A—hindbrain—autistic disorder	0.00179	0.0129	CbGeAlD
Nortriptyline—DRD2—hindbrain—autistic disorder	0.00176	0.0127	CbGeAlD
Nortriptyline—ADRA1D—forebrain—autistic disorder	0.00173	0.0125	CbGeAlD
Nortriptyline—ADRA1D—telencephalon—autistic disorder	0.00159	0.0115	CbGeAlD
Nortriptyline—CHRM4—head—autistic disorder	0.00142	0.0102	CbGeAlD
Nortriptyline—CHRM4—nervous system—autistic disorder	0.00134	0.00968	CbGeAlD
Nortriptyline—CHRM2—forebrain—autistic disorder	0.00133	0.00957	CbGeAlD
Nortriptyline—HTR2C—brainstem—autistic disorder	0.00132	0.00955	CbGeAlD
Nortriptyline—CHRM4—central nervous system—autistic disorder	0.00129	0.00932	CbGeAlD
Nortriptyline—HTR2C—forebrain—autistic disorder	0.00128	0.00922	CbGeAlD
Nortriptyline—HTR6—head—autistic disorder	0.00127	0.00914	CbGeAlD
Nortriptyline—SLC6A4—brainstem—autistic disorder	0.00126	0.00906	CbGeAlD
Nortriptyline—CHRM2—telencephalon—autistic disorder	0.00122	0.0088	CbGeAlD
Nortriptyline—SLC6A4—forebrain—autistic disorder	0.00121	0.00874	CbGeAlD
Nortriptyline—CHRM1—forebrain—autistic disorder	0.00121	0.00871	CbGeAlD
Nortriptyline—HTR6—nervous system—autistic disorder	0.0012	0.00866	CbGeAlD
Nortriptyline—HTR2C—telencephalon—autistic disorder	0.00118	0.00848	CbGeAlD
Nortriptyline—HTR2A—hindbrain—autistic disorder	0.00116	0.00836	CbGeAlD
Nortriptyline—HTR6—central nervous system—autistic disorder	0.00116	0.00834	CbGeAlD
Nortriptyline—HTR1A—brainstem—autistic disorder	0.00111	0.00804	CbGeAlD
Nortriptyline—SLC6A4—telencephalon—autistic disorder	0.00111	0.00804	CbGeAlD
Nortriptyline—CHRM1—telencephalon—autistic disorder	0.00111	0.00801	CbGeAlD
Nortriptyline—CHRM5—head—autistic disorder	0.00111	0.00798	CbGeAlD
Nortriptyline—SLC6A2—brainstem—autistic disorder	0.00111	0.00797	CbGeAlD
Nortriptyline—CHRM3—forebrain—autistic disorder	0.00108	0.00779	CbGeAlD
Nortriptyline—HTR1A—forebrain—autistic disorder	0.00108	0.00776	CbGeAlD
Nortriptyline—SLC6A2—forebrain—autistic disorder	0.00107	0.0077	CbGeAlD
Nortriptyline—CYP2D6—hindbrain—autistic disorder	0.00106	0.00762	CbGeAlD
Nortriptyline—CHRM5—nervous system—autistic disorder	0.00105	0.00757	CbGeAlD
Nortriptyline—ADRA1A—brainstem—autistic disorder	0.00103	0.00741	CbGeAlD
Nortriptyline—CHRM4—brain—autistic disorder	0.00103	0.0074	CbGeAlD
Nortriptyline—ADRA1B—head—autistic disorder	0.00101	0.00729	CbGeAlD
Nortriptyline—CHRM5—central nervous system—autistic disorder	0.00101	0.00728	CbGeAlD
Nortriptyline—DRD2—brainstem—autistic disorder	0.00101	0.00727	CbGeAlD
Nortriptyline—CHRM3—telencephalon—autistic disorder	0.000993	0.00717	CbGeAlD
Nortriptyline—ADRA1A—forebrain—autistic disorder	0.000992	0.00716	CbGeAlD
Nortriptyline—HTR1A—telencephalon—autistic disorder	0.00099	0.00714	CbGeAlD
Nortriptyline—ADRA1D—head—autistic disorder	0.000989	0.00713	CbGeAlD
Nortriptyline—SLC6A2—telencephalon—autistic disorder	0.000981	0.00708	CbGeAlD
Nortriptyline—DRD2—eye—autistic disorder	0.000981	0.00707	CbGeAlD
Nortriptyline—DRD2—forebrain—autistic disorder	0.000972	0.00701	CbGeAlD
Nortriptyline—ADRA1B—nervous system—autistic disorder	0.000958	0.00691	CbGeAlD
Nortriptyline—ADRA1D—nervous system—autistic disorder	0.000938	0.00676	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—autistic disorder	0.000923	0.00666	CbGeAlD
Nortriptyline—HTR6—brain—autistic disorder	0.000918	0.00662	CbGeAlD
Nortriptyline—ADRA1A—telencephalon—autistic disorder	0.000912	0.00658	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—autistic disorder	0.000903	0.00651	CbGeAlD
Nortriptyline—DRD2—telencephalon—autistic disorder	0.000894	0.00645	CbGeAlD
Nortriptyline—SLC6A4—digestive system—autistic disorder	0.000851	0.00614	CbGeAlD
Nortriptyline—CHRM5—brain—autistic disorder	0.000802	0.00578	CbGeAlD
Nortriptyline—HRH1—eye—autistic disorder	0.000775	0.00559	CbGeAlD
Nortriptyline—ORM1—nervous system—autistic disorder	0.000772	0.00557	CbGeAlD
Nortriptyline—HRH1—forebrain—autistic disorder	0.000768	0.00554	CbGeAlD
Nortriptyline—CHRM2—head—autistic disorder	0.000759	0.00548	CbGeAlD
Nortriptyline—CHRM3—digestive system—autistic disorder	0.000758	0.00547	CbGeAlD
Nortriptyline—ORM1—central nervous system—autistic disorder	0.000743	0.00536	CbGeAlD
Nortriptyline—ADRA1B—brain—autistic disorder	0.000733	0.00528	CbGeAlD
Nortriptyline—HTR2C—head—autistic disorder	0.000732	0.00528	CbGeAlD
Nortriptyline—CHRM2—nervous system—autistic disorder	0.00072	0.00519	CbGeAlD
Nortriptyline—ADRA1D—brain—autistic disorder	0.000717	0.00517	CbGeAlD
Nortriptyline—PTGS1—forebrain—autistic disorder	0.000711	0.00513	CbGeAlD
Nortriptyline—HRH1—telencephalon—autistic disorder	0.000706	0.00509	CbGeAlD
Nortriptyline—CYP2C19—digestive system—autistic disorder	0.000705	0.00508	CbGeAlD
Nortriptyline—Amitriptyline—NTRK2—autistic disorder	0.000703	0.0801	CrCbGaD
Nortriptyline—HTR2C—nervous system—autistic disorder	0.000694	0.00501	CbGeAlD
Nortriptyline—SLC6A4—head—autistic disorder	0.000694	0.00501	CbGeAlD
Nortriptyline—CHRM2—central nervous system—autistic disorder	0.000693	0.005	CbGeAlD
Nortriptyline—CHRM1—head—autistic disorder	0.000691	0.00499	CbGeAlD
Nortriptyline—CYP2E1—telencephalon—autistic disorder	0.000678	0.00489	CbGeAlD
Nortriptyline—HTR2C—central nervous system—autistic disorder	0.000668	0.00482	CbGeAlD
Nortriptyline—HTR2A—brainstem—autistic disorder	0.000664	0.00479	CbGeAlD
Nortriptyline—SLC6A4—nervous system—autistic disorder	0.000658	0.00475	CbGeAlD
Nortriptyline—CHRM1—nervous system—autistic disorder	0.000655	0.00473	CbGeAlD
Nortriptyline—PTGS1—telencephalon—autistic disorder	0.000654	0.00471	CbGeAlD
Nortriptyline—HTR2A—eye—autistic disorder	0.000647	0.00467	CbGeAlD
Nortriptyline—HTR2A—forebrain—autistic disorder	0.000641	0.00463	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—autistic disorder	0.000633	0.00457	CbGeAlD
Nortriptyline—CHRM1—central nervous system—autistic disorder	0.000631	0.00455	CbGeAlD
Nortriptyline—CHRM3—head—autistic disorder	0.000619	0.00446	CbGeAlD
Nortriptyline—HTR1A—head—autistic disorder	0.000616	0.00444	CbGeAlD
Nortriptyline—SLC6A2—head—autistic disorder	0.000611	0.00441	CbGeAlD
Nortriptyline—CYP2D6—brainstem—autistic disorder	0.000605	0.00437	CbGeAlD
Nortriptyline—HTR2A—telencephalon—autistic disorder	0.00059	0.00425	CbGeAlD
Nortriptyline—CHRM3—nervous system—autistic disorder	0.000587	0.00423	CbGeAlD
Nortriptyline—CYP2D6—forebrain—autistic disorder	0.000584	0.00421	CbGeAlD
Nortriptyline—HTR1A—nervous system—autistic disorder	0.000584	0.00421	CbGeAlD
Nortriptyline—SLC6A2—nervous system—autistic disorder	0.000579	0.00418	CbGeAlD
Nortriptyline—CYP1A2—digestive system—autistic disorder	0.000576	0.00415	CbGeAlD
Nortriptyline—ADRA1A—head—autistic disorder	0.000568	0.0041	CbGeAlD
Nortriptyline—CHRM3—central nervous system—autistic disorder	0.000565	0.00407	CbGeAlD
Nortriptyline—HTR1A—central nervous system—autistic disorder	0.000562	0.00406	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—autistic disorder	0.000558	0.00402	CbGeAlD
Nortriptyline—DRD2—head—autistic disorder	0.000557	0.00402	CbGeAlD
Nortriptyline—CYP3A5—digestive system—autistic disorder	0.000555	0.00401	CbGeAlD
Nortriptyline—CHRM2—brain—autistic disorder	0.00055	0.00397	CbGeAlD
Nortriptyline—HTR1A—cerebellum—autistic disorder	0.00055	0.00397	CbGeAlD
Nortriptyline—CYP2C9—digestive system—autistic disorder	0.000547	0.00394	CbGeAlD
Nortriptyline—HRH1—digestive system—autistic disorder	0.000539	0.00389	CbGeAlD
Nortriptyline—ADRA1A—nervous system—autistic disorder	0.000539	0.00388	CbGeAlD
Nortriptyline—CYP2D6—telencephalon—autistic disorder	0.000537	0.00387	CbGeAlD
Nortriptyline—HTR2C—brain—autistic disorder	0.00053	0.00383	CbGeAlD
Nortriptyline—DRD2—nervous system—autistic disorder	0.000528	0.00381	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—autistic disorder	0.000518	0.00374	CbGeAlD
Nortriptyline—CYP2E1—digestive system—autistic disorder	0.000518	0.00374	CbGeAlD
Nortriptyline—ALB—brain—autistic disorder	0.000518	0.00373	CbGeAlD
Nortriptyline—DRD2—central nervous system—autistic disorder	0.000508	0.00367	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—autistic disorder	0.000507	0.00366	CbGeAlD
Nortriptyline—SLC6A4—brain—autistic disorder	0.000503	0.00363	CbGeAlD
Nortriptyline—CHRM1—brain—autistic disorder	0.000501	0.00361	CbGeAlD
Nortriptyline—Atomoxetine—HTR1D—autistic disorder	0.000499	0.0569	CrCbGaD
Nortriptyline—PTGS1—digestive system—autistic disorder	0.000499	0.0036	CbGeAlD
Nortriptyline—DRD2—cerebellum—autistic disorder	0.000497	0.00358	CbGeAlD
Nortriptyline—Mianserin—HTR1D—autistic disorder	0.000488	0.0556	CrCbGaD
Nortriptyline—Protriptyline—SLC6A4—autistic disorder	0.000456	0.052	CrCbGaD
Nortriptyline—HTR2A—digestive system—autistic disorder	0.00045	0.00325	CbGeAlD
Nortriptyline—CHRM3—brain—autistic disorder	0.000448	0.00323	CbGeAlD
Nortriptyline—HTR1A—brain—autistic disorder	0.000447	0.00322	CbGeAlD
Nortriptyline—SLC6A2—brain—autistic disorder	0.000443	0.00319	CbGeAlD
Nortriptyline—HRH1—head—autistic disorder	0.00044	0.00317	CbGeAlD
Nortriptyline—CYP2E1—head—autistic disorder	0.000422	0.00305	CbGeAlD
Nortriptyline—HRH1—nervous system—autistic disorder	0.000417	0.00301	CbGeAlD
Nortriptyline—CYP3A4—digestive system—autistic disorder	0.000417	0.00301	CbGeAlD
Nortriptyline—Trimipramine—HTR3A—autistic disorder	0.000415	0.0473	CrCbGaD
Nortriptyline—ADRA1A—brain—autistic disorder	0.000412	0.00297	CbGeAlD
Nortriptyline—Trimipramine—HTR1D—autistic disorder	0.000411	0.0468	CrCbGaD
Nortriptyline—CYP2D6—digestive system—autistic disorder	0.00041	0.00296	CbGeAlD
Nortriptyline—PTGS1—head—autistic disorder	0.000407	0.00294	CbGeAlD
Nortriptyline—DRD2—brain—autistic disorder	0.000403	0.00291	CbGeAlD
Nortriptyline—HRH1—central nervous system—autistic disorder	0.000401	0.00289	CbGeAlD
Nortriptyline—CYP2E1—nervous system—autistic disorder	0.000401	0.00289	CbGeAlD
Nortriptyline—PTGS1—nervous system—autistic disorder	0.000386	0.00278	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—autistic disorder	0.000386	0.00278	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—autistic disorder	0.000377	0.00272	CbGeAlD
Nortriptyline—PTGS1—central nervous system—autistic disorder	0.000372	0.00268	CbGeAlD
Nortriptyline—HTR2A—head—autistic disorder	0.000367	0.00265	CbGeAlD
Nortriptyline—HTR2A—nervous system—autistic disorder	0.000348	0.00251	CbGeAlD
Nortriptyline—HTR2A—central nervous system—autistic disorder	0.000335	0.00242	CbGeAlD
Nortriptyline—CYP2D6—head—autistic disorder	0.000335	0.00241	CbGeAlD
Nortriptyline—Clomipramine—GSTP1—autistic disorder	0.000334	0.038	CrCbGaD
Nortriptyline—HTR2A—cerebellum—autistic disorder	0.000328	0.00236	CbGeAlD
Nortriptyline—CYP3A4—nervous system—autistic disorder	0.000322	0.00232	CbGeAlD
Nortriptyline—HRH1—brain—autistic disorder	0.000319	0.0023	CbGeAlD
Nortriptyline—CYP2D6—nervous system—autistic disorder	0.000317	0.00229	CbGeAlD
Nortriptyline—CYP3A4—central nervous system—autistic disorder	0.00031	0.00224	CbGeAlD
Nortriptyline—CYP2E1—brain—autistic disorder	0.000306	0.00221	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—autistic disorder	0.000305	0.0022	CbGeAlD
Nortriptyline—Amitriptyline—HTR1D—autistic disorder	0.000303	0.0345	CrCbGaD
Nortriptyline—CYP2D6—cerebellum—autistic disorder	0.000298	0.00215	CbGeAlD
Nortriptyline—Atomoxetine—HTR1B—autistic disorder	0.000296	0.0338	CrCbGaD
Nortriptyline—PTGS1—brain—autistic disorder	0.000295	0.00213	CbGeAlD
Nortriptyline—Mianserin—DRD3—autistic disorder	0.000281	0.032	CrCbGaD
Nortriptyline—HTR2A—brain—autistic disorder	0.000266	0.00192	CbGeAlD
Nortriptyline—Cyclobenzaprine—HTR2A—autistic disorder	0.000262	0.0298	CrCbGaD
Nortriptyline—Epinastine—HTR2A—autistic disorder	0.00026	0.0296	CrCbGaD
Nortriptyline—Chlorprothixene—DRD3—autistic disorder	0.000256	0.0292	CrCbGaD
Nortriptyline—Chlorprothixene—DRD1—autistic disorder	0.000251	0.0286	CrCbGaD
Nortriptyline—CYP2D6—brain—autistic disorder	0.000242	0.00175	CbGeAlD
Nortriptyline—Maprotiline—HTR2A—autistic disorder	0.000224	0.0255	CrCbGaD
Nortriptyline—Amitriptyline—OPRM1—autistic disorder	0.00022	0.0251	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A4—autistic disorder	0.0002	0.0228	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—autistic disorder	0.000198	0.0226	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—autistic disorder	0.000196	0.0223	CrCbGaD
Nortriptyline—Amitriptyline—HTR1B—autistic disorder	0.00018	0.0205	CrCbGaD
Nortriptyline—Clomipramine—SLC6A4—autistic disorder	0.000179	0.0204	CrCbGaD
Nortriptyline—Amitriptyline—DRD3—autistic disorder	0.000174	0.0199	CrCbGaD
Nortriptyline—Trimipramine—SLC6A4—autistic disorder	0.000165	0.0188	CrCbGaD
Nortriptyline—Desipramine—ADRB2—autistic disorder	0.000159	0.0181	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—autistic disorder	0.000157	0.0179	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—autistic disorder	0.000154	0.0175	CrCbGaD
Nortriptyline—Mianserin—HTR2A—autistic disorder	0.00015	0.0171	CrCbGaD
Nortriptyline—Desipramine—SLC6A4—autistic disorder	0.000144	0.0164	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—autistic disorder	0.000137	0.0157	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—autistic disorder	0.000137	0.0156	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—autistic disorder	0.000126	0.0144	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—autistic disorder	0.000122	0.0139	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—autistic disorder	0.000121	0.0138	CrCbGaD
Nortriptyline—Doxepin—HTR2A—autistic disorder	0.000121	0.0137	CrCbGaD
Nortriptyline—Desipramine—HTR2A—autistic disorder	0.000111	0.0126	CrCbGaD
Nortriptyline—Imipramine—HTR2A—autistic disorder	9.38e-05	0.0107	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—autistic disorder	9.32e-05	0.0106	CrCbGaD
Nortriptyline—ADRA1A—Signaling Pathways—LEP—autistic disorder	5.62e-06	2.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—autistic disorder	5.62e-06	2.3e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HRAS—autistic disorder	5.59e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PRKCB—autistic disorder	5.5e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—autistic disorder	5.49e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	5.46e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—autistic disorder	5.46e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	5.43e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—autistic disorder	5.43e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.41e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PRKCB—autistic disorder	5.41e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—COMT—autistic disorder	5.4e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PRKCB—autistic disorder	5.4e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PRKCB—autistic disorder	5.38e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTP1—autistic disorder	5.38e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PLA2G4A—autistic disorder	5.37e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTM1—autistic disorder	5.37e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—autistic disorder	5.37e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MAOA—autistic disorder	5.36e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PRKCB—autistic disorder	5.36e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PTEN—autistic disorder	5.36e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—COMT—autistic disorder	5.36e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HRAS—autistic disorder	5.35e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—autistic disorder	5.35e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.33e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTP1—autistic disorder	5.33e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MAOA—autistic disorder	5.32e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PRKCB—autistic disorder	5.31e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	5.3e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	5.3e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—autistic disorder	5.29e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APC—autistic disorder	5.26e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CG—autistic disorder	5.26e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—autistic disorder	5.25e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAT—autistic disorder	5.23e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—autistic disorder	5.22e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	5.21e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGF—autistic disorder	5.2e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	5.2e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAT—autistic disorder	5.19e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	5.18e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	5.18e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APC—autistic disorder	5.18e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CG—autistic disorder	5.17e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CG—autistic disorder	5.16e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APC—autistic disorder	5.16e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CG—autistic disorder	5.16e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	5.15e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APC—autistic disorder	5.15e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GPX1—autistic disorder	5.15e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—autistic disorder	5.14e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APC—autistic disorder	5.13e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	5.13e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—autistic disorder	5.12e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGF—autistic disorder	5.12e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGF—autistic disorder	5.1e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGF—autistic disorder	5.09e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	5.08e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APC—autistic disorder	5.08e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGF—autistic disorder	5.07e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APC—autistic disorder	5.07e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	5.07e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PTEN—autistic disorder	5.05e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	5.03e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGF—autistic disorder	5.02e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGF—autistic disorder	5.01e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—autistic disorder	5.01e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	4.96e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.94e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTM1—autistic disorder	4.94e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—autistic disorder	4.93e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—autistic disorder	4.92e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP19A1—autistic disorder	4.92e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—autistic disorder	4.92e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—autistic disorder	4.92e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—autistic disorder	4.91e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—autistic disorder	4.9e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PLA2G4A—autistic disorder	4.9e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTM1—autistic disorder	4.9e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—autistic disorder	4.88e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DHFR—autistic disorder	4.85e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PTEN—autistic disorder	4.84e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—autistic disorder	4.84e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—autistic disorder	4.84e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—autistic disorder	4.82e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—autistic disorder	4.82e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—autistic disorder	4.81e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—MAPK1—autistic disorder	4.79e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—autistic disorder	4.75e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—autistic disorder	4.74e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—HRAS—autistic disorder	4.74e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GPX1—autistic disorder	4.73e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—autistic disorder	4.73e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	4.72e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—autistic disorder	4.71e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—MAPK1—autistic disorder	4.71e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—autistic disorder	4.7e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GPX1—autistic disorder	4.69e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	4.69e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	4.68e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—autistic disorder	4.66e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—autistic disorder	4.65e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—autistic disorder	4.64e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	4.63e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.62e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	4.62e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTEN—autistic disorder	4.58e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—COMT—autistic disorder	4.58e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SERPINE1—autistic disorder	4.57e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTP1—autistic disorder	4.56e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PTEN—autistic disorder	4.55e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MAOA—autistic disorder	4.54e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	4.5e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SERPINE1—autistic disorder	4.49e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	4.48e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	4.46e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CG—autistic disorder	4.44e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAT—autistic disorder	4.43e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—autistic disorder	4.42e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	4.42e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	4.41e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HRAS—autistic disorder	4.38e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—autistic disorder	4.37e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HRAS—autistic disorder	4.36e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MAPK1—autistic disorder	4.36e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—autistic disorder	4.33e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—autistic disorder	4.23e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—autistic disorder	4.22e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—autistic disorder	4.19e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—autistic disorder	4.19e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PLA2G4A—autistic disorder	4.19e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—autistic disorder	4.19e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	4.17e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—autistic disorder	4.17e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK1—autistic disorder	4.11e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—autistic disorder	4.07e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTEN—autistic disorder	4.06e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—autistic disorder	4.03e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—autistic disorder	4.01e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—autistic disorder	4.01e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—autistic disorder	3.99e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CG—autistic disorder	3.99e-06	1.64e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PTEN—autistic disorder	3.97e-06	1.63e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PTEN—autistic disorder	3.95e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK1—autistic disorder	3.94e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—autistic disorder	3.93e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—autistic disorder	3.92e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HRAS—autistic disorder	3.85e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.8e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—autistic disorder	3.8e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—HRAS—autistic disorder	3.79e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HRAS—autistic disorder	3.78e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PTEN—autistic disorder	3.78e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HRAS—autistic disorder	3.77e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—autistic disorder	3.75e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—autistic disorder	3.72e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	3.71e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—autistic disorder	3.7e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	3.7e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—autistic disorder	3.7e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—autistic disorder	3.68e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.67e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—autistic disorder	3.64e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CG—autistic disorder	3.64e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—autistic disorder	3.63e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—autistic disorder	3.62e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—autistic disorder	3.62e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—autistic disorder	3.62e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—autistic disorder	3.61e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—autistic disorder	3.6e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—autistic disorder	3.59e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—autistic disorder	3.58e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—autistic disorder	3.57e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—autistic disorder	3.56e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—autistic disorder	3.55e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—autistic disorder	3.53e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—autistic disorder	3.52e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOA—autistic disorder	3.51e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—autistic disorder	3.5e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—autistic disorder	3.49e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—autistic disorder	3.48e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—autistic disorder	3.46e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—autistic disorder	3.44e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—autistic disorder	3.43e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—autistic disorder	3.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—autistic disorder	3.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—autistic disorder	3.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—autistic disorder	3.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—autistic disorder	3.41e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—autistic disorder	3.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—autistic disorder	3.37e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—autistic disorder	3.36e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—autistic disorder	3.36e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—autistic disorder	3.35e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—autistic disorder	3.3e-06	1.35e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.23e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—autistic disorder	3.23e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK1—autistic disorder	3.22e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK1—autistic disorder	3.21e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—autistic disorder	3.16e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—autistic disorder	3.16e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—autistic disorder	3.11e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—autistic disorder	3.09e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	3.07e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—autistic disorder	3.03e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—autistic disorder	3.02e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—autistic disorder	2.97e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—autistic disorder	2.96e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—autistic disorder	2.94e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—autistic disorder	2.86e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—autistic disorder	2.84e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK1—autistic disorder	2.83e-06	1.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK1—autistic disorder	2.79e-06	1.14e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—autistic disorder	2.79e-06	1.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK1—autistic disorder	2.78e-06	1.14e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK1—autistic disorder	2.77e-06	1.14e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK1—autistic disorder	2.76e-06	1.13e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—autistic disorder	2.76e-06	1.13e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK1—autistic disorder	2.74e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	2.73e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—autistic disorder	2.66e-06	1.09e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—autistic disorder	2.64e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—autistic disorder	2.59e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—autistic disorder	2.58e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—autistic disorder	2.48e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—autistic disorder	2.47e-06	1.01e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—autistic disorder	2.47e-06	1.01e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—autistic disorder	2.43e-06	9.96e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—autistic disorder	2.41e-06	9.88e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.4e-06	9.84e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—autistic disorder	2.36e-06	9.68e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—autistic disorder	2.36e-06	9.68e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—autistic disorder	2.28e-06	9.36e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—autistic disorder	2.27e-06	9.32e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—autistic disorder	2.24e-06	9.17e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—autistic disorder	2.23e-06	9.15e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.22e-06	9.12e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—autistic disorder	2.22e-06	9.09e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.2e-06	9.01e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—autistic disorder	2.19e-06	8.98e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—autistic disorder	2.18e-06	8.92e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—autistic disorder	2.14e-06	8.78e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—autistic disorder	2.14e-06	8.76e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—autistic disorder	2.13e-06	8.73e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—autistic disorder	2.12e-06	8.7e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—autistic disorder	2.1e-06	8.62e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—autistic disorder	2.1e-06	8.6e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—autistic disorder	2.06e-06	8.44e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—autistic disorder	1.82e-06	7.47e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—autistic disorder	1.59e-06	6.51e-06	CbGpPWpGaD
